Showing results (31-40 of 64) with videos related to

Sort By:
Pageof 7
Gastro Hep Advances|August 12, 2024
COVID-19 Pandemic Impact on Diagnosis, Stage, and Treatment of Hepatocellular Carcinoma in the United StatesBhupinder Kaur, Yee Hui Yeo, Jeff Liang, et al.
Hepatology (Baltimore, Md.)|April 16, 2022
Racial and ethnic disparities in early treatment with immunotherapy for advanced HCC in the United StatesJoseph C Ahn, Marie Lauzon, Michael Luu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 22, 2016
Effectiveness and Safety of Sofosbuvir-Based Regimens for Chronic HCV Genotype 3 Infection: Results of the HCV-TARGET StudyJordan J Feld, Raoel Maan, Stefan Zeuzem, et al.
Radiology|January 8, 2011
Estimation of hepatic proton-density fat fraction by using MR imaging at 3.0 TTakeshi Yokoo, Masoud Shiehmorteza, Gavin Hamilton, et al.
Hepatology (Baltimore, Md.)|January 6, 2022
Patient-reported outcomes in HCC: A scoping review by the Practice Metrics Committee of the American Association for the Study of Liver DiseasesMarina Serper, Neehar D Parikh, Grace Thiele, et al.
Clinical and Translational Gastroenterology|June 3, 2024
Impact of the Early COVID-19 Pandemic on Incidence and Outcomes of Hepatocellular Carcinoma in the United StatesJeff Liang, Yi-Te Lee, Yee Hui Yeo, et al.
ACG Case Reports Journal|March 25, 2024
Correction to: Amanita Mushroom Toxin Poisoning in Los Angeles CountyParker G Jobin, Connor Stewart, Aarshi Vipani, et al.
ACG Case Reports Journal|January 1, 2024
Amanita Mushroom Toxin Poisoning in Los Angeles CountyParker G Jobin, Connor Stewart, Aarshi Vipani, et al.
Hepatology (Baltimore, Md.)|March 28, 2025
Comparative effectiveness of immunotherapy versus lenvatinib in advanced hepatocellular carcinoma: A real-world analysis using target trial emulationJoseph C Ahn, Wee Han Ng, Yee Hui Yeo, et al.
Scientific Reports|February 18, 2018
Prevalence and impact of baseline resistance-associated substitutions on the efficacy of ledipasvir/sofosbuvir or simeprevir/sofosbuvir against GT1 HCV infectionGary P Wang, Norah Terrault, Jacqueline D Reeves, et al.
Pageof 7